Raphas Co (XKRX:214260) ROE % Adjusted to Book Value : -7.55% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Raphas Co ROE % Adjusted to Book Value?

Raphas Co's ROE % for the quarter that ended in Dec. 2023 was -42.30%. Raphas Co's PB Ratio for the quarter that ended in Dec. 2023 was 5.60. Raphas Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -7.55%.

Raphas Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Raphas Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raphas Co ROE % Adjusted to Book Value Chart

Raphas Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

0.11

-2.14

1.40

-5.55

-4.46

Raphas Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-8.08	-0.70	-5.50	-4.74	-7.55

Competitive Comparison of Raphas Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Raphas Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raphas Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Raphas Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Raphas Co's ROE % Adjusted to Book Value falls into.

Raphas Co ROE % Adjusted to Book Value Calculation

Raphas Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-24.99%	/	5.60
	=	-4.46%

Raphas Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-42.30%	/	5.60
	=	-7.55%

Raphas Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Raphas Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Raphas Co (XKRX:214260) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Raphas Co Ltd (XKRX:214260) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

62, Magokjungang 8-ro 1-gil, Gangseo-gu, Seoul, KOR, 07793

Website

http://www.raphas.com

Raphas Co Ltd is engaged in the development of a drug delivery system. The company's products include Acropass, Cosmetics ODM, and Medical Contract Manufacturing Services. Its products are mostly used in biomedical products and all-natural cosmetic materials.

Raphas Co (XKRX:214260) Headlines

No Headlines